These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25595840)

  • 21. The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.
    Swierczak A; Cook AD; Lenzo JC; Restall CM; Doherty JP; Anderson RL; Hamilton JA
    Cancer Immunol Res; 2014 Aug; 2(8):765-76. PubMed ID: 25005824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune regulation of therapy-resistant niches: emerging targets for improving anticancer drug responses.
    Jinushi M
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):737-45. PubMed ID: 24756203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-associated macrophages: implications in cancer immunotherapy.
    Petty AJ; Yang Y
    Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor.
    Brownlow N; Mol C; Hayford C; Ghaem-Maghami S; Dibb NJ
    Leukemia; 2009 Mar; 23(3):590-4. PubMed ID: 18784745
    [No Abstract]   [Full Text] [Related]  

  • 25. [Impact of molecular targeting therapy on tumor immunity].
    Jinushi M; Akita H
    Nihon Rinsho; 2015 Aug; 73(8):1349-54. PubMed ID: 26281689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravital imaging reveals distinct responses of depleting dynamic tumor-associated macrophage and dendritic cell subpopulations.
    Lohela M; Casbon AJ; Olow A; Bonham L; Branstetter D; Weng N; Smith J; Werb Z
    Proc Natl Acad Sci U S A; 2014 Nov; 111(47):E5086-95. PubMed ID: 25385645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.
    Lao L; Fan S; Song E
    Adv Exp Med Biol; 2017; 1026():331-370. PubMed ID: 29282692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Microenvironment of Lung Cancer and Therapeutic Implications.
    Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
    Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic targeting of tumor-associated macrophages and microglia in glioblastoma.
    Bowman RL; Joyce JA
    Immunotherapy; 2014; 6(6):663-6. PubMed ID: 25041027
    [No Abstract]   [Full Text] [Related]  

  • 31. The possible mechanisms of tumor progression via CSF-1/CSF-1R pathway activation.
    Huang L; Xu X; Hao Y
    Rom J Morphol Embryol; 2014; 55(2 Suppl):501-6. PubMed ID: 25178319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment.
    Liu C; Li Z; Wang L; Tong L; He N; Chen Y; Liu Y; Wu Z; Sun P; Xiang R; Ren G; Su W
    Biomed Res Int; 2015; 2015():974615. PubMed ID: 25883982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophages at the crossroads of anticancer strategies.
    Cortese N; Donadon M; Rigamonti A; Marchesi F
    Front Biosci (Landmark Ed); 2019 Jun; 24(7):1271-1283. PubMed ID: 31136979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages and therapeutic resistance in cancer.
    Ruffell B; Coussens LM
    Cancer Cell; 2015 Apr; 27(4):462-72. PubMed ID: 25858805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
    Obermueller E; Vosseler S; Fusenig NE; Mueller MM
    Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology and therapeutic targeting of tumour-associated macrophages.
    Beltraminelli T; De Palma M
    J Pathol; 2020 Apr; 250(5):573-592. PubMed ID: 32086811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Taming of the TAMs.
    Seoane J
    Trends Cell Biol; 2016 Aug; 26(8):562-563. PubMed ID: 27394965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collagen VI in cancer and its biological mechanisms.
    Chen P; Cescon M; Bonaldo P
    Trends Mol Med; 2013 Jul; 19(7):410-7. PubMed ID: 23639582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
    Joshi S; Singh AR; Zulcic M; Durden DL
    Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor microenvironment components: Allies of cancer progression.
    Ribeiro Franco PI; Rodrigues AP; de Menezes LB; Pacheco Miguel M
    Pathol Res Pract; 2020 Jan; 216(1):152729. PubMed ID: 31735322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.